E103* (p.Glu103Ter) variant of CD40LG (CD40 ligand)
E103* (p.Glu103Ter) in CD40LG (CD40 ligand) is a protein-truncating change. Clinical records from UniProt describe it as variant assessed as somatic; high impact. The record also includes structural context.
E103* (p.Glu103Ter) variant details
- p.Glu103Ter
- NCI-TCGA TCGA novel
- Ensembl rs2076113150
- Variant assessed as somatic; high impact.
- Stop Gained
- UniProt: Variant assessed as somatic; high impact.
- Structural context available